1. Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
   Kei Takuma et al, 2022, International Journal of Molecular Sciences CrossRef
2. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma
   Veronica Zelli et al, 2022, Frontiers in Oncology CrossRef
3. miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
   Patricia de la Cruz-Ojeda et al, 2022, Cells CrossRef
4. The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
   Francesca Matilde Schipilliti et al, 2021, Pharmaceuticals CrossRef
5. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
   Man Yao et al, 2023, Frontiers in Pharmacology CrossRef
6. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma
   Shaoming Song et al, 2022, Expert Review of Molecular Diagnostics CrossRef
7. Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development
   Abhijit Pal et al, 2021, Nature Reviews Clinical Oncology CrossRef
8. Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star
   Wangyang Zheng et al, 2021, Molecular Cancer Therapeutics CrossRef
9. A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma
   Shan-Qiang Zhang et al, 2022, Journal of Dental Sciences CrossRef